In 1981, the DEA submitted a notice of intention to place ketamine in Schedule III on the Managed Substances Act, but proof of genuine abuse was scarce and didn't aid the designation. According to the severity from the patient’s indicators, at times prescribers advise lozenges In combination with an IV https://ketalinic.com/our-products/